Roxane Laboratories, Inc. Announces the Launch of Balsalazide Disodium Capsules, 750mg
COLUMBUS, Ohio, Jan. 2 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Balsalazide Disodium Capsules, 750mg by the U.S. Food and Drug Administration. The product is available in bottles of 280 capsules for immediate ship...National Pharmaceutical Company to Sponsor Popular Kansas City Walk
...CTOCORT(R) Cream (Hydrocortisone Cream, USP) 1% and PROCTOCORT(R) Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 mg. Vapreotide acetate, balsalazide tablet, granulated mesalamine and XIFAXAN(R) for additional indications are under development. ...National Pharmaceutical Company to Sponsor Popular Indianapolis Walk
...CTOCORT(R) Cream (Hydrocortisone Cream, USP) 1% and PROCTOCORT(R) Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 mg. Vapreotide acetate, balsalazide tablet, granulated mesalamine and XIFAXAN(R) for additional indications are under development. ...Salix Pharmaceuticals Previews Digestive Disease Week 2007
...ore colon cancer screening colonoscopy COLAZAL Efficacy and safety of balsalazide for J. Quiros May 22 treatment of pediatric patients with ... (Hydrocortisone Cream, USP) and PROCTOCORT(R) (Hydrocortisone Cream, USP). balsalazide disodium tablets, granulated mesalamine, SANVAR(R) (600 ug vials vapreotide...Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
...nd efficacy of a new 1100 mg tablet formulation of balsalazide disodium (balsalazide tablets). Balsalazide disodi...s of our placebo-controlled, multi-center study of balsalazide tablets, which was conducted solely in the U.S. Wh...ater proportion of subjects dosed twice daily with balsalazide tablets for eight weeks achieved clinical improvem...Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
PITTSBURGH, Dec. 31 /PRNewswire-FirstCall/ Mylan Inc. (NYSE: MYL ) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Balsalazide Disodium Capsules, 750 mg. Balsalaz...